Fulcher JA, Shoptaw S, Makgoeng SB, et al. Brief report: recent methamphetamine use is associated with increased rectal mucosal inflammatory cytokines, regardless of HIV-1 serostatus. JAIDS J Acquir Immune Defic Syndr. 2018;78(1):119–23. https://doi.org/10.1097/QAI.0000000000001643.

Article  CAS  PubMed  Google Scholar 

Liu Y, Meng FZ, Wang X, et al. Methamphetamine facilitates HIV infection of primary human monocytes through inhibiting cellular viral restriction factors. Cell Biosci. 2021;11(1):194. https://doi.org/10.1186/s13578-021-00703-4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Doshi RK, Vogenthaler NS, Lewis S, Rodriguez A, Metsch L, Rio Cdel. Correlates of antiretroviral utilization among hospitalized HIV-infected crack cocaine users. AIDS Res Hum Retroviruses. 2012;28(9):1007–14. https://doi.org/10.1089/aid.2011.0329.

Article  CAS  PubMed  Google Scholar 

Cepeda JA, Vickerman P, Bruneau J, et al. Estimating the contribution of stimulant injection to HIV and HCV epidemics among people who inject drugs and implications for harm reduction: a modeling analysis. Drug Alcohol Depend. 2020;213:108135. https://doi.org/10.1016/j.drugalcdep.2020.108135.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Grov C, Westmoreland D, Morrison C, Carrico AW, Nash D. The crisis we are not talking about: one-in-three annual HIV seroconversions among sexual and gender minorities were persistent methamphetamine users. JAIDS J Acquir Immune Defic Syndr. 2020;85(3):272–9. https://doi.org/10.1097/QAI.0000000000002461.

Article  PubMed  Google Scholar 

NIDA. What is the scope of methamphetamine use in the United States? 2024. Accessed February 10, 2024. https://nida.nih.gov/publications/research-reports/methamphetamine/what-scope-methamphetamine-misuse-in-united-states

Jones CM, Houry D, Han B, Baldwin G, Vivolo-Kantor A, Compton WM. Methamphetamine use in the United States: epidemiological update and implications for prevention, treatment, and harm reduction. Ann N Y Acad Sci. 2022;1508(1):3–22. https://doi.org/10.1111/nyas.14688.

Article  CAS  PubMed  Google Scholar 

Han B, Compton WM, Jones CM, Einstein EB, Volkow ND. Methamphetamine use, methamphetamine use disorder, and associated overdose deaths among US adults. JAMA Psychiatr. 2021;78(12):1329. https://doi.org/10.1001/jamapsychiatry.2021.2588.

Article  Google Scholar 

NIHCM Foundation. Stimulant deaths on the rise, compounded by rise in synthetic opioids. Published Online May 13, 2021. https://nihcm.org/publications/stimulant-deaths-on-the-rise-compounded-by-rise-in-synthetic-opioids

Tashkin DP. Evidence implicating cocaine as a possible risk factor for HIV infection. J Neuroimmunol. 2004;147(1–2):26–7. https://doi.org/10.1016/j.jneuroim.2003.10.010.

Article  CAS  PubMed  Google Scholar 

Lawson KS, Prasad A, Groopman JE. Methamphetamine enhances HIV-1 replication in CD4 + t-cells via a novel IL-1β auto-regulatory loop. Front Immunol. 2020;11:136. https://doi.org/10.3389/fimmu.2020.00136.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tyagi M, Bukrinsky M, Simon L. Mechanisms of HIV transcriptional regulation by drugs of abuse. CHR. 2016;14(5):442–54. https://doi.org/10.2174/1570162X14666160324124736.

Article  CAS  Google Scholar 

Passaro RC, Pandhare J, Qian HZ, Dash C. The complex interaction between methamphetamine abuse and HIV-1 pathogenesis. J Neuroimmune Pharmacol. 2015;10(3):477–86. https://doi.org/10.1007/s11481-015-9604-2.

Article  PubMed  PubMed Central  Google Scholar 

Horvath KJ, Carrico AW, Simoni J, Boyer EW, Amico KR, Petroll AE. Engagement in HIV medical care and technology use among stimulant-using and nonstimulant-using men who have sex with men. AIDS Res Treat. 2013;2013:1–11. https://doi.org/10.1155/2013/121352.

Article  Google Scholar 

Jin H, Ogunbajo A, Mimiaga MJ, et al. Over the influence: the HIV care continuum among methamphetamine-using men who have sex with men. Drug Alcohol Depend. 2018;192:125–8. https://doi.org/10.1016/j.drugalcdep.2018.07.038.

Article  PubMed  PubMed Central  Google Scholar 

Carrico AW, Jain J, Discepola MV, et al. A community-engaged randomized controlled trial of an integrative intervention with HIV-positive, methamphetamine-using men who have sex with men. BMC Public Health. 2016;16(1):673. https://doi.org/10.1186/s12889-016-3325-1.

Article  PubMed  PubMed Central  Google Scholar 

Carrico AW, Hunt PW, Neilands TB, et al. Stimulant use and viral suppression in the era of universal antiretroviral therapy. JAIDS J Acquir Immune Defic Syndr. 2019;80(1):89–93. https://doi.org/10.1097/QAI.0000000000001867.

Article  PubMed  Google Scholar 

Metzger DS, Woody GE, O’Brien CP. Drug treatment as HIV prevention: A research update. JAIDS J Acquir Immune Defic Syndr. 2010;55(Supplement 1):S32–6. https://doi.org/10.1097/QAI.0b013e3181f9c10b.

Article  PubMed  Google Scholar 

Fauci AS, Redfield RR, Sigounas G, Weahkee MD, Giroir BP. Ending the HIV epidemic: a plan for the united states. JAMA. 2019;321(9):844. https://doi.org/10.1001/jama.2019.1343.

Article  PubMed  Google Scholar 

Gómez W, Olem D, Andrews R, et al. Optimizing contingency management with Methamphetamine-Using men who have sex with men. Cogn Behav Pract. 2018;25(2):286–95. https://doi.org/10.1016/j.cbpra.2017.08.003.

Article  Google Scholar 

Roll JM, Petry NM, Stitzer ML, et al. Contingency management for the treatment of methamphetamine use disorders. AJP. 2006;163(11):1993–9. https://doi.org/10.1176/ajp.2006.163.11.1993.

Article  Google Scholar 

Menza TW, Jameson DR, Hughes JP, Colfax GN, Shoptaw S, Golden MR. Contingency management to reduce methamphetamine use and sexual risk among men who have sex with men: a randomized controlled trial. BMC Public Health. 2010;10(1):774. https://doi.org/10.1186/1471-2458-10-774.

Article  PubMed  PubMed Central  Google Scholar 

Festinger DS, Dugosh KL, Kirby KC, Seymour BL. Contingency management for cocaine treatment: cash vs. vouchers. J Subst Abuse Treat. 2014;47(2):168–74. https://doi.org/10.1016/j.jsat.2014.03.001.

Article  PubMed  PubMed Central  Google Scholar 

Colfax GN, Santos GM, Das M, et al. Mirtazapine to reduce methamphetamine use: a randomized controlled trial. Arch Gen Psychiatry. 2011;68(11):1168–75. https://doi.org/10.1001/archgenpsychiatry.2011.124.

Article  PubMed  PubMed Central  Google Scholar 

Coffin PO, Santos GM, Hern J, et al. Effects of mirtazapine for methamphetamine use disorder among cisgender men and transgender women who have sex with men: a placebo-controlled randomized clinical trial. JAMA Psychiatr. 2020;77(3):246. https://doi.org/10.1001/jamapsychiatry.2019.3655.

Article  Google Scholar 

Trivedi MH, Walker R, Ling W, et al. Bupropion and naltrexone in methamphetamine use disorder. N Engl J Med. 2021;384(2):140–53. https://doi.org/10.1056/NEJMoa2020214.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chan B, Kondo K, Freeman M, Ayers C, Montgomery J, Kansagara D. Pharmacotherapy for cocaine use disorder—a systematic review and meta-analysis. J Gen Intern Med. 2019;34(12):2858–73. https://doi.org/10.1007/s11606-019-05074-8.

Article  PubMed  PubMed Central  Google Scholar 

Tauscher JS, DePue MK, Swank J, Salloum RG. Determinants of preference for telehealth versus in-person treatment for substance use disorders: a discrete choice experiment. J Subst Use Addict Treat. 2023;146:208938. https://doi.org/10.1016/j.josat.2022.208938.

Article  CAS  PubMed  Google Scholar 

Moore BA, Rosen MI, Wang Y, et al. A remotely-delivered CBT and contingency management therapy for substance using people with HIV. AIDS Behav. 2015;19(0 2):156–62. https://doi.org/10.1007/s10461-014-0990-x.

Article  PubMed  PubMed Central  Google Scholar 

Palmateer N, Hamill V, Bergenstrom A, et al. Interventions to prevent HIV and hepatitis C among people who inject drugs: latest evidence of effectiveness from a systematic review (2011 to 2020). Int J Drug Policy. 2022;109:103872. https://doi.org/10.1016/j.drugpo.2022.103872.

Article  PubMed  Google Scholar